Immunome Inc.

IMNM | NASDAQ

Price Alert Chart Builder DCF Calculator

$25.07

+$1.10 (+4.59%)

At close: Sep 21, 2026, 4:00 PM ET

$25.07

$0 (0.00%)

Pre-market: Sep 22, 2026, 7:24 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $2.4B

Enterprise Value $1.88B

Beta 2.13

Average Volume 1.27M

Shares Outstanding (Diluted) 113.27M

Shares Change YoY 30.18%

Institutional Ownership N/A

Exchange NASDAQ

ISIN US45257U1088

Price Performance

Price Change 1M -12.0%

Price Change 3M 29.7%

Price Change 6M 23.5%

Price Change YTD 20.4%

Price Change 1Y 156.6%

Price Change 3Y 246.5%

Price Change 5Y -9.7%

1M CAGR (ann.) 0.2%

1Y CAGR (ann.) 154.5%

5Y CAGR (ann.) 3.8%

All-Time CAGR 11.0%

Valuation

PE Ratio -9.87

Forward PE N/A

PEG Ratio -0.59

Forward PEG -1.59

PS Ratio N/A

Forward PS 44.90

PB Ratio 4.56

P/FCF Ratio -10.94

P/Adj. FCF Ratio -9.57

P/OCF Ratio -13.62

EV/Sales N/A

EV/EBIT -7.40

EV/EBITDA -7.49

EV/FCF -8.59

Earnings Yield -10.1%

FCF Yield -9.1%

Adj. FCF Yield -10.4%

Financial Health

Net Cash $515.41M

Total Debt $4.59M

Cash & Short-Term Investments $520M

Total Assets $565.38M

Current Ratio 15.08

Quick Ratio 15.08

Debt / Equity Ratio 0.01

Debt / EBITDA -0.02

Debt / FCF -0.02

OCF / Debt -45.51

Interest Coverage 0.00

Altman Z-Score 33.15

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -14.3%

Returns

Return on Assets -45.0%

Return on Equity -50.6%

Return on Invested Capital -51.1%

Return on Capital Employed -51.1%

Return on Tangible Assets -45.0%

Historical Growth (CAGR)

Revenue CAGR 3Y -69.2%

Revenue CAGR 5Y 9.9%

Revenue CAGR 10Y N/A

EPS CAGR 3Y 97.6%

EPS CAGR 5Y 0.1%

EPS CAGR 10Y N/A

FCF CAGR 3Y -48.9%

FCF CAGR 5Y -58.5%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 13

EPS Growth Next 3Y 27.3%

Revenue Growth Next 3Y N/A

Earnings Date Nov 4, 2026

EPS Estimate (next Q) -$0.64

EPS Growth Est (next Q) -1.5%

Revenue Est (next Q) $200K

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $35.25

Price Target Upside 40.6%

Cash Flow

Operating Cash Flow $-208.79M

Free Cash Flow $-219.09M

Adj. Free Cash Flow $-250.48M

FCF Per Share -$1.93

OCF Per Share -$1.84

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-49.95M

Operating Income $-270.47M

EBITDA $-251.25M

Net Income $-254.32M

EPS (Diluted) -$2.54

Revenue / Employee N/A

Profit / Employee $-1.03M

Employees 247